Issuers took a breather in August, as just 10 IPOs priced on $992.2M in proceeds during the month, below the year-ago period’s 17 debuts on $4.2B. While August was the slowest month since February 2013 (eight deals on $848.7M in proceeds), it was on par for the month in terms of historical figures, as there has been an average of 10 IPOs for $2.2B in August going back to 2001. Continuing with recent trends, Healthcare led the month with $309.9M raised from four IPOs. Meanwhile, the U.S.-Based 25 climbed 14.7% in August, the largest monthly gain since March’s 23.3% return. Overall, only four issuers broke the 10.0% offer/1-day mark, led by Healthcare’s T2 Biosystems (+30.2%), which also closed out the month 111.0% above offer price.